期刊文献+

全国多中心类风湿关节炎患者残疾及功能受限情况的调查 被引量:105

A multicenter study of deformity and disabmty in rheumatoid arthritis patients in China
原文传递
导出
摘要 目的了解类风湿关节炎(RA)患者的残疾及功能受限情况,分析RA导致残疾及功能受限的影响因素。方法应用问卷方式回顾性调查340例RA患者的残疾情况,应用健康评定量表残疾指数(HAQ.DI)评价患者功能受限情况。采用SPSS13.0软件对残疾及HAQ.DI的影响因素进行单因素及多因素Logistic多元回归分析。结果①根据3种不同的标准,RA患者中残疾的发生率分别为50.3%(171/340)、36.8%(125/340)及18.8%(64/340),且均随病程的延长而增加。最常见的受累关节依次为腕关节(111/340,32.6%)、近端指间关节(82/340,24.1%〉及肘关节(69/340,20.3%)。对影响残疾的因素进行Logistic多元回归分析,结果显示女性[比值比(DR)=5.179,95%可信区间(CI):1.593~16.836,P=0.006]、病程较长(OR=1.104,95%CI:1.065-1.146,P=0.ooo)、存在关节外表现(OR=3.813,95%CI:1.814-8.011,P=0.000)及医生可视模拟评分(VAS)疾病活动评分较高(OR=1.392,95%CI:1.230-1.577,P=0.000)是RA患者发生残疾的独立危险因素(P〈0.05,R2=0.345)。②RA患者中68.5%(233/340)存在不同程度的功能受限,其中31.3%(120/340)存在轻度功能受限,19.7%(67/340)中度功能受限,13.5%(461340)重度功能受限。Logistic多元回归分析结果提示年龄较大(DR=1.028,95%CI:1.012-1.046,P=0.001)、医生VAS疾病活动评分较高(OR=1.603,95%Ch1.311-1.958,P=0.000)及从未规律应用过改善病情抗风湿药(DMARD8)(OR=1.721,95%CI:1.054~2.809,P=0.030)是导致患者功能受限的独立危险因素(P〈0.05,RZ=0.384)。结论RA患者残疾及功能受限发生率高,且随病程延长而增加。高龄、女性、病程较长、存在关节外表现、医生疾病活动VAS评分较高及从未规律应用过DMARDs是导致RA患者残疾和(或)功能受限的独立危险因素。 Objective To describe the condition of deformity and disability in rheumatoid arthritis patients in China, and to analyze the factors that may affect deformity and disability. Methods Data were obtained from a cross-section survey of 340 patients with rheumatoid arthritis (RA), selected from Department of Rheumatology in 21 general hospitals across China. Demographic data, clinical data and Stanford health assessment questionnaire disability index (HAQ-DI) scores were collected. Univariate analysis and Logistic multiple regression were performed to determine independent prognostic factors of deformity and disability. Results ① Occurrence of deformity differed by three different standards [50.3% (171/340), 36.8% (125/340) and 18.8%(64/340) respectively], and increased with the disease course in rheumatoid arthritis patients. The most common joints involved were wrist (111/340, 32.6% ), proximal interphalangeal joint (82/340, 24.1% ) and elbow (69/340, 20.3% ). Multiple regression analysis showed that female gender (0R=5.179, 95%CI: 1.593-16.836, P=0.006), long disease course (OR=1.104, 95%CI: 1.065-1.146, P=0.000), presence of extra-artieular manifestations (0R=3.813, 95%CI: 1.814-8.011, P=0.000)and high physieian VAS disease activity score (0R=1.392, 95%CI: 1.230-1.577, P=0.000) were independent risk factors for deformity (P〈0.05). ② The median HAQ-DI score for rheumatoid arthritis patients was 0.500 points (interquartile range, 0 to 1.250). Ordinal Logistic regression showed that elder (0R=1.028, 95%CI: 1.012-1.046, P=0.001), higher physician VAS disease activity score (0R=1.603, 95%CI: 1.311-1.958, P=0.000) and never used disease-modifying antirheumatic drugs (DMARDs) regularly (0R=1.721, 95%CI: 1.054-2.809, P=0.030) eould predict severe disability independently (P〈0.05). Conclusion Rheumatoid arthritis patients are at high risk of deformity and disability. Deformity is associated with female gender, long disease course, presence of extra-articular manifestations and high physician VAS disease aetivity score. Disability could be predicted by elder, high physician VAS disease activity score and never used DMARDs regularly.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第8期526-532,共7页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 残疾人 健康调查 Arthritis, rheumatoid Disabled persons Health surveys
  • 相关文献

参考文献16

  • 1Li R, Sun J, Ben LM, et al. Epidemiology of eight common rheumatic diseases in China:a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford), 2012, 51 : 721-729.
  • 2刘栩栩,贾园,安媛,何菁,粟占国.类风湿关节炎患者就医及治疗现状分析[J].中华风湿病学杂志,2008,12(9):637-639. 被引量:34
  • 3粟占国.类风湿关节炎在我国的低认知度和高致残率不容忽视[J].中华医学杂志,2009,89(27):1873-1875. 被引量:45
  • 4刘栩,贾园,安媛,何菁,栗占国.类风湿关节炎患者发病形式和临床特点的现况调查[J].中日友好医院学报,2008,22(5):266-269. 被引量:7
  • 5王秀茹,苏茵,安媛,周云杉,王莉枝,王彩虹,李小峰,陈丽娜,朱平,卢昕,王国春,靳洪涛,杨荣,王永福,李光韬,张卓莉,孙琳,刘湘源,陶杰梅,张风肖,杨静,李振彬,韦美秋,林金盈,舒荣,崔刘福,柯丹,刘晓敏,叶丛,胡绍先,李昊,杨岫岩,赖蓓,高明,黄慈波,宋立军,李兴福,栗占国.全国多中心类风湿关节炎患者门诊用药费用的调查[J].中华风湿病学杂志,2010,14(6):368-372. 被引量:25
  • 6Bruce B, Fries JF. The Sta ord health assessment questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol, 2003, 30: 167-178.
  • 7Scott DL, Pugner K, Kaarela K, et al. The links between joint damage and disability in rheumatoid arthritis. Bheumatology, 2000, 39: 122-132.
  • 8Van der Heijde DM, van Leeuwen MA, van Rid PL, et al. Bian-nual radiographic assessments of hands and feet al in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum, 1992, 35: 26-34.
  • 9Plant MJ, Jones PW, Saklatvala J, et al. Patterns of radio|ogieal progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol, 1998, 25: 417-426.
  • 10Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum, 1998, 41: 1571-1582.

二级参考文献33

  • 1栗占国.风湿性疾病的规范化治疗势在必行[J].北京大学学报(医学版),2006,38(4):341-344. 被引量:6
  • 2栗占国.规范化治疗——风湿病领域永恒的话题[J].中华风湿病学杂志,2007,11(6):321-323. 被引量:11
  • 3杨学义,张霞.160例类风湿性关节炎临床分析[J].社区医学杂志,2007,5(06X):48-49. 被引量:2
  • 4Emery P.Evidence supporting the benefit of early intervention in rheumatoid arthritis.J Rheumatol.2002,66:Suppl.3-8.
  • 5Peck JR,Smith TW.Ward JR,et al.Disability and depression in rheamatoid arthritis:a multi-trial.multi-method investigation.Arthritis Rheum.1989,32:1100-1106.
  • 6Grigor C,Capeli H,Stiding A,et al.Effect of a treatment strategy of fight control for rheumatoid arthritis (The TICORA study):a single-blind randomized controlled trial.Lancet,2004,364:263-269.
  • 7Saag KG,Teng GG,Patkar NM,et al.American College of Rheumatology.American College of Rheumatology 2008 recommendations for the use of nonbiologie and biologic diseasemodifying antirheumatie drugs in rheumatoid arthritis.Arthritis Rheum,2008,59:726-784.
  • 8Rantalaiho V,Korpela M,Hannonen P,et al.FIN-RACo Trial Group.The good initial response to therapy with a combination of traditional disease-modifying antirheumatie drugs is sustained over time:the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.Arthritis Rheum,2009,60:1222-1231.
  • 9Choy EH,Smith C,DoréCJ,et al.A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.Rheumatology,2005,44:1414-1421.
  • 10Visser K,Katehamart W,Loza E,et al.Multinational evidencebased recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis:integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiation.Ann Rheum Dis,2009,58:1086-1093.

共引文献99

同被引文献1168

引证文献105

二级引证文献1322

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部